Technology in Parkinson's disease: Challenges and opportunities

Movement Disorders

Volumn 31, Issue 9, 2016, Pages 1272-1282

  Espay, Alberto J ^a   Bonato, Paolo ^b   Nahab, Fatta B ^c   Maetzler, Walter ^d,e   Dean, John M ^f   Klucken, Jochen ^g   Eskofier, Bjoern M ^h   Merola, Aristide ⁱ   Horak, Fay ^j,k   Lang, Anthony E ^l   Reilmann, Ralf ^d,m,n   Giuffrida, Joe ^o   Nieuwboer, Alice ^p   Horne, Malcolm ^q   Little, Max A ^r,s   Litvan, Irene ^c   Simuni, Tanya ^t   Dorsey, E Ray ^u   Burack, Michelle A ^u   Kubota, Ken ^v   Kamondi, Anita ^w   Godinho, Catarina ^x   Daneault, Jean Francois ^b   Mitsi, Georgia ^y   Krinke, Lothar ^z   Hausdorff, Jeffery M ^aa   Bloem, Bastiaan R ^ab   Papapetropoulos, Spyros ^ac   more..

^a UNIVERSITY OF CINCINNATI   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^f Davis Phinney Foundation for Parkinson's   (United States)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^j PORTLAND VA MEDICAL CENTER   (United States)

^k APDM Inc   (United States)

^l TORONTO WESTERN HOSPITAL   (Canada)

^m George Huntington Institute   (Germany)

ⁿ UNIVERSITY OF MÜNSTER   (Germany)

^o Great Lakes NeuroTechnologies Inc   (United States)

^p KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^q UNIVERSITY OF MELBOURNE   (Australia)

^r ASTON UNIVERSITY   (United Kingdom)

^s MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^t NORTHWESTERN UNIVERSITY   (United States)

^u UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^v THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^w National Institute of Clinical Neuroscience   (Hungary)

^x INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

^y Apptomics LLC   (United States)

^z MEDTRONIC INC   (United States)

^aa TEL AVIV UNIVERSITY   (Israel)

^ab RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^ac MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

digital biomarkers; digital health; eHealth; Parkinson's disease; precision medicine; remote monitoring; technology; wearable technology

Indexed keywords

ANALYTIC METHOD; ARTICLE; COMMERCIAL PHENOMENA; ECOLOGICAL VALIDITY; HUMAN; MEDICAL CARE; MEDICAL TECHNOLOGY; PARKINSON DISEASE; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; REMOTE SENSING; SENSOR;

EID: 84985911015     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26642     Document Type: Article

References (63)

1. Pasluosta CF, Gassner H, Winkler J, Klucken J, Eskofier BM. An emerging era in the management of parkinson's disease: wearable technologies and the internet of things. IEEE J Biomed Health Inform 2015;19(6):1873–1881.
2. Wang H, Jafari R, Zhou G, et al. Guest Editorial: Special Issue on Internet of Things for Smart and Connected Health. IEEE IoT J 2015;2(1):1–4.
3. Ozinga SJ, Machado AG, Miller Koop M, Rosenfeldt AB, Alberts JL. Objective assessment of postural stability in Parkinson's disease using mobile technology. Mov Disord 2015;30(9):1214–1221.
4. Horak FB, Mancini M. Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors. Mov Disord 2013;28(11):1544–1551.
5. Mariani B, Jimenez MC, Vingerhoets FJ, Aminian K. On-shoe wearable sensors for gait and turning assessment of patients with Parkinson's disease. IEEE Trans Biomed Eng 2013;60(1):155–158.
6. Cavanaugh JT, Ellis TD, Earhart GM, Ford MP, Foreman KB, Dibble LE. Capturing ambulatory activity decline in Parkinson's disease. J Neurol Phys Ther 2012;36(2):51–57.
7. Rahimi F, Bee C, Duval C, et al. Using ecological whole body kinematics to evaluate effects of medication adjustment in Parkinson disease. J Parkinsons Dis 2014;4(4):617–627.
8. Papapetropoulos S, Mitsi G, Espay AJ. Digital health revolution: is it time for affordable remote monitoring for Parkinson's disease? Front Neurol 2015;6:34.
9. Shull PB, Jirattigalachote W, Hunt MA, Cutkosky MR, Delp SL. Quantified self and human movement: a review on the clinical impact of wearable sensing and feedback for gait analysis and intervention. Gait Posture 2014;40(1):11–19.
10. Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR. Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013;28(12):1628–1637.
11. Bonato P. Wearable sensors and systems. From enabling technology to clinical applications. IEEE Eng Med Biol Mag 2010;29(3):25–36.
12. Espay AJ, Giuffrida JP, Chen R, et al. Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord 2011;26(14):2504–2508.
13. Goetz CG, Stebbins GT, Wolff D, et al. Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at-home testing device. Mov Disord 2009;24(4):551–556.
14. Klucken J, Barth J, Kugler P, et al. Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease. PLoS ONE 2013;8(2):e56956.
15. Chen BR, Patel S, Buckley T, et al. A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors. IEEE Trans Biomed Eng 2011;58(3):831–836.
16. Stamford JA, Schmidt PN, Friedl KE. What engineering technology could do for quality of life in Parkinson's disease: a review of current needs and opportunities. IEEE J Biomed Health Inform 2015;19(6):1862–1872.
17. Guo Y, Graber A, McBurney RN, Balasubramanian R. Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms. BMC Bioinformatics 2010;11:447.
18. Roy SH, Cole BT, Gilmore LD, et al. High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity. Mov Disord 2013;28(8):1080–1087.
19. Mera TO, Burack MA, Giuffrida JP. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology. Conf Proc IEEE Eng Med Biol Soc 2012;2012:154–157.
20. Das S, Trutoiu L, Murai A, et al. Quantitative measurement of motor symptoms in Parkinson's disease: a study with full-body motion capture data. Conf Proc IEEE Eng Med Biol Soc 2011;2011:6789–6792.
21. Shen X, Mak MK. Technology-assisted balance and gait training reduces falls in patients with Parkinson's disease: a randomized controlled trial with 12-month follow-up. Neurorehabil Neural Repair 2015;29(2):103–111.
22. Weiss A, Herman T, Giladi N, Hausdorff JM. Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days. PLoS ONE 2014;9(5):e96675.
23. McCall C, McCall WV. Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs. J Sleep Res 2012;21(1):122–127.
24. Liu G, Ho C, Slappey N, et al. A wearable conductivity sensor for wireless real-time sweat monitoring. Sensors Actuat B Chem 2016;227:35–42.
25. Caldara M, Colleoni C, Guido E, Re V, Rosace G. Optical monitoring of sweat pH by a textile fabric wearable sensor based on covalently bonded litmus-3-glycidoxypropyltrimethoxysilane coating. Sensors Actuat B Chem 2016;222:213–220.
26. Cazalé A, Sant W, Ginot F, et al. Physiological stress monitoring using sodium ion potentiometric microsensors for sweat analysis. Sensors Actuat B Chem 2016;225:1–9.
27. Solla P, Cadeddu C, Cannas A, et al. Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype. J Neural Transm 2015:1–6.
28. Sommerauer M, Imbach LL, Jarallah M, Baumann CR, Valko PO. Diminished event-related cortical arousals and altered heart rate response in Parkinson's disease. Mov Disord 2015;30(6):866–870.
29. Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF. Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2015;21(7):723–728.
30. Nieuwboer A, De Weerdt W, Dom R, Lesaffre E. A frequency and correlation analysis of motor deficits in Parkinson patients. Disabil Rehabil 1998;20(4):142–150.
31. Brun L, Lefaucheur R, Fetter D, et al. Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients. Clin Neurol Neurosurg 2014;127:93–96.
32. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord 2005;20(suppl 11):S11–S16.
33. Patel S, Lorincz K, Hughes R, et al. Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors. IEEE Trans Inf Technol Biomed 2009;13(6):864–873.
34. Moore ST, Yungher DA, Morris TR, et al. Autonomous identification of freezing of gait in Parkinson's disease from lower-body segmental accelerometry. J Neuroeng Rehabil 2013;10:19.
35. Lee SI, Daneault J-F, Golabchi FN, et al. A novel method for assessing the severity of levodopa-induced dyskinesia using wearable sensors. In: Engineering in Medicine and Biology Society (EMBC), 2015 37th Annual International Conference of the IEEE. Conf Proc IEEE Eng Med Biol Soc; 2015:8087–8090.
36. Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE. Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? Parkinsonism Relat Disord 2011;17(9):693–697.
37. Berganzo K, Tijero B, Gonzalez-Eizaguirre A, et al. Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups. Neurologia 2014, pii: S0213-4853(14)00233-3, doi: 10.1016/j.nrl.2014.10.010.
38. Dubey H, Goldberg JC, Abtahi M, Mahler L, Mankodiya K. EchoWear: smartwatch technology for voice and speech treatments of patients with Parkinson's disease. In: Proceedings from the Conference on Wireless Health. ACM, New York, NY, USA; 2015.
39. Bayestehtashk A, Asgari M, Shafran I, McNames J. Fully automated assessment of the severity of Parkinson's disease from speech. Comput Speech Lang 2015;29(1):172–185.
40. Maetzler W, Liepelt I, Berg D. Progression of Parkinson's disease in the clinical phase: potential markers. Lancet Neurol 2009;8(12):1158–1171.
41. Valappil RA, Black JE, Broderick MJ, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord 2010;25(14):2296–2303.
42. Hung SW, Adeli GM, Arenovich T, Fox SH, Lang AE. Patient perception of dyskinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81(10):1112–1115.
43. Horak F, King L, Mancini M. Role of body-worn movement monitor technology for balance and gait rehabilitation. Phys Ther 2015;95(3):461–470.
44. Fisher JM, Hammerla NY, Rochester L, Andras P, Walker RW. Body-worn sensors in Parkinson's disease: evaluating their acceptability to patients. Telemed J E Health 2016;22:63–69.
45. Ledger D, McCaffrey D. Inside wearables: how the science of human behavior change offers the secret to long-term engagement. In: LLC EP, Dan Ledger and Daniel McCarey, eds. Endeavour Partners LLC; Cambridge, MA, 2014;1–17.
46. Consumer Intelligence Series: The Wearable Future. Pricewaterhouse Coopers. http://www.pwc.com/us/en/retail-consumer/publications/assets/pwc-cis-wearable-future.pdf
47. Ferreira JJ, Godinho C, Santos AT, et al. Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability study. BMC Neurol 2015;15:89.
48. Lieber B, Taylor BE, Appelboom G, McKhann G, Connolly ES Jr. Motion sensors to assess and monitor medical and surgical management of Parkinson disease. World Neurosurg 2015;84(2):561–566.
49. Arora S, Venkataraman V, Zhan A, et al. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: a pilot study. Parkinsonism Relat Disord 2015;21(6):650–653.
50. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol 2014;71(4):499–504.
51. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 2015;72(8):863–873.
52. Mazilu S, Calatroni A, Gazit E, Mirelman A, Hausdorff JM, Troster G. Prediction of freezing of gait in parkinson's from physiological wearables: an exploratory study. IEEE J Biomed Health Inform 2015;19(6):1843–1854.
53. Bachlin M, Plotnik M, Roggen D, et al. Wearable assistant for Parkinson's disease patients with the freezing of gait symptom. IEEE Trans Inf Technol Biomed 2010;14(2):436–446.
54. Rampp A, Barth J, Schulein S, Gassmann KG, Klucken J, Eskofier BM. Inertial sensor-based stride parameter calculation from gait sequences in geriatric patients. IEEE Trans Biomed Eng 2015;62(4):1089–1097.
55. Mendiola MF, Kalnicki M, Lindenauer S. Valuable features in mobile health apps for patients and consumers: content analysis of apps and user ratings. JMIR Mhealth Uhealth 2015;3(2):e40.
56. Hubble RP, Naughton GA, Silburn PA, Cole MH. Wearable sensor use for assessing standing balance and walking stability in people with Parkinson's disease: a systematic review. PLoS ONE 2015;10(4):e0123705.
57. Del Din S, Godfrey A, Rochester L. Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson's disease: toward clinical and at home use. IEEE J Biomed Health Inform 2015 [Epub ahead of print].
58. FirstWord. Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma. Doctor's Guide Publishing Limited; 2015. http://www.fwreports.com/patient-centric-mobile-apps-key-opportunities-and-challenges-for-pharma/#.Vwl_mWQrL-Y
59. Zheng YL, Ding XR, Poon CC, et al. Unobtrusive sensing and wearable devices for health informatics. IEEE Trans Biomed Eng 2014;61(5):1538–1554.
60. Son D, Lee J, Qiao S, et al. Multifunctional wearable devices for diagnosis and therapy of movement disorders. Nat Nanotechnol 2014;9(5):397–404.
61. Quinn EJ, Blumenfeld Z, Velisar A, et al. Beta oscillations in freely moving Parkinson's subjects are attenuated during deep brain stimulation. Mov Disord 2015;30:1750–1758.
62. Basu I, Graupe D, Tuninetti D, et al. Pathological tremor prediction using surface electromyogram and acceleration: potential use in “ON-OFF” demand driven deep brain stimulator design. J Neural Eng 2013;10(3):036019.
63. Shukla P, Basu I, Tuninetti D. Towards closed-loop deep brain stimulation: decision tree-based essential tremor patient's state classifier and tremor reappearance predictor. Conf Proc IEEE Eng Med Biol Soc 2014;2014:2605–2608.